Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparison of pegylated interferon α‐2b plus psoralen PUVA versus standard interferon α‐2a plus PUVA in patients with cutaneous T‐cell lymphoma
A.C. Hüsken, Athanasios Tsianakas, Peter Hensen, et al.
Journal of the European Academy of Dermatology and Venereology (2011) Vol. 26, Iss. 1, pp. 71-78
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017
Franz Trautinger, Johanna Eder, Chalid Assaf, et al.
European Journal of Cancer (2017) Vol. 77, pp. 57-74
Open Access | Times Cited: 418
Guidelines for phototherapy of mycosis fungoides and Sézary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium
Elise A. Olsen, Emilia Hodak, Thomas F. Anderson, et al.
Journal of the American Academy of Dermatology (2015) Vol. 74, Iss. 1, pp. 27-58
Open Access | Times Cited: 159
British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018
D. Gilson, Sean Whittaker, Fiona Child, et al.
British Journal of Dermatology (2018) Vol. 180, Iss. 3, pp. 496-526
Closed Access | Times Cited: 131
S2k‐Guidelines – Cutaneous lymphomas (ICD10 C82 ‐ C86): Update 2021
Edgar Dippel, Chalid Assaf, Jürgen C. Becker, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2022) Vol. 20, Iss. 4, pp. 537-554
Open Access | Times Cited: 39
Erdheim-Chester Disease: Characteristics and Management
Javier Muñoz, Filip Janků, Philip R. Cohen, et al.
Mayo Clinic Proceedings (2014) Vol. 89, Iss. 7, pp. 985-996
Open Access | Times Cited: 83
Real-world study of pegylated interferon α-2a to treat mycosis fungoides/Sézary syndrome using time to next treatment as a measure of clinical benefit: an EORTC CLTG study
Keila Mitsunaga, M. Bagot, C. Ram‐Wolff, et al.
British Journal of Dermatology (2024) Vol. 191, Iss. 3, pp. 419-427
Closed Access | Times Cited: 7
The Use of Interferons in the Treatment of Cutaneous T-Cell Lymphoma
Natalie Spaccarelli, Alain H. Rook
Dermatologic Clinics (2015) Vol. 33, Iss. 4, pp. 731-745
Open Access | Times Cited: 63
Tumor-associated M2 macrophages in mycosis fungoides acquire immunomodulatory function by interferon alpha and interferon gamma
Sadanori Furudate, Taku Fujimura, Aya Kakizaki, et al.
Journal of Dermatological Science (2016) Vol. 83, Iss. 3, pp. 182-189
Closed Access | Times Cited: 51
S2k‐Leitlinie – Kutane Lymphome (ICD10 C82–C86): Update 2021
Edgar Dippel, Chalid Assaf, Jürgen C. Becker, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2022) Vol. 20, Iss. 4, pp. 537-555
Open Access | Times Cited: 22
Orbital and ocular adnexal histiocytic tumors; a multidisciplinary literature review
Seyed Mohammad Malakooti Shijani, Mohsen Bahmani Kashkouli, Mercia Gondim, et al.
Orbit (2025), pp. 1-13
Closed Access
Systematic review of combination therapies for mycosis fungoides
Daniel Humme, Alexander Nast, R. Erdmann, et al.
Cancer Treatment Reviews (2014) Vol. 40, Iss. 8, pp. 927-933
Closed Access | Times Cited: 45
Interventions for mycosis fungoides
Tobias Weberschock, Reinhard Strametz, Maria Lorenz, et al.
Cochrane library (2012)
Closed Access | Times Cited: 41
Interventions for mycosis fungoides
Arash Valipour, Manuel Jäger, Peggy A. Wu, et al.
Cochrane library (2020) Vol. 2020, Iss. 7
Open Access | Times Cited: 28
Pegylated interferon‐α2a in cutaneous T‐cell lymphoma – a multicenter retrospective data analysis with 70 patients
Inga Hansen, Glenn Geidel, Finn Abeck, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 11, pp. 1489-1497
Open Access | Times Cited: 2
Dose‐escalation study evaluating pegylated interferon alpha‐2a in patients with cutaneous T‐cell lymphoma
M. Schiller, Athanasios Tsianakas, Wolfram Sterry, et al.
Journal of the European Academy of Dermatology and Venereology (2017) Vol. 31, Iss. 11, pp. 1841-1847
Closed Access | Times Cited: 22
Mycosis fungoides and Sézary syndrome: focus on the current treatment scenario
José Antônio Sanches, Jade Cury‐Martins, Rodrigo Martins Abreu, et al.
Anais Brasileiros de Dermatologia (2021) Vol. 96, Iss. 4, pp. 458-471
Open Access | Times Cited: 14
Standardization of regimens in Narrowband UVB and PUVA in early stage mycosis fungoides: position paper from the Italian Task Force for Cutaneous Lymphomas
Vieri Grandi, Paolo Fava, Serena Rupoli, et al.
Journal of the European Academy of Dermatology and Venereology (2017) Vol. 32, Iss. 5, pp. 683-691
Closed Access | Times Cited: 15
Systemic therapy for cutaneous T-cell lymphoma: who, when, what, and why?
Pooja Virmani, Susan Hwang, Justin G. Hastings, et al.
Expert Review of Hematology (2016) Vol. 10, Iss. 2, pp. 111-121
Closed Access | Times Cited: 14
The efficacy of long‐term psoralen plus ultraviolet A and low‐dose interferon‐a combination therapy in mycosis fungoides: A literature review
Hatice Şanlı, İncilay Kalay Yıldızhan, Kaan Gündüz, et al.
Photodermatology Photoimmunology & Photomedicine (2024) Vol. 40, Iss. 4
Open Access | Times Cited: 1
The use of pegylated interferon a‐2a in a cohort of Greek patients with mycosis fungoides
Aikaterini Patsatsi, Evangelia Papadavid, Aikaterini Kyriakou, et al.
Journal of the European Academy of Dermatology and Venereology (2021) Vol. 36, Iss. 4
Closed Access | Times Cited: 11
Non-pegylated and Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma and the Risk of Severe Ocular Side-effects
Jana D. Albrecht, Nadia Ninosu, Denise Barry, et al.
Acta Dermato Venereologica (2022) Vol. 102, pp. adv00722-adv00722
Open Access | Times Cited: 5
PUVA and interferon α2b combined therapy for patients with mycosis fungoides at different stages of the disease: a seven‐year retrospective study in Russia
Olga Yu. Olisova, Matteo Megna, Ekaterina V. Grekova, et al.
Journal of the European Academy of Dermatology and Venereology (2018) Vol. 33, Iss. 2
Closed Access | Times Cited: 6
Mycosis fungoides and Sézary syndrome: Australian clinical practice statement
Friyana Bhabha, Christopher McCormack, Jillian Wells, et al.
Australasian Journal of Dermatology (2020) Vol. 62, Iss. 1
Open Access | Times Cited: 6
Clinical Trial of High-Dose Pegylated-Interferon-Alfa-2b Combined With Phototherapy in Advanced Stage Mycosis Fungoides
Christina J. Walker, Maria L. Espinosa, Neha Mehta‐Shah, et al.
Journal of Drugs in Dermatology (2021) Vol. 20, Iss. 3, pp. 349-350
Open Access | Times Cited: 6
A Rare Case of Erdheim-Chester Disease (Non-Langerhans Cell Histiocytosis) with Concurrent Langerhans Cell Histiocytosis: A Diagnostic and Therapeutic Challenge
Hamza Hashmi, Drew Murray, John C. Greenwell, et al.
Case Reports in Hematology (2018) Vol. 2018, pp. 1-6
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top